Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'nevirapine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 182 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
      Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Skowron, G; Street, JC; Obee, EM
      Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Meroni, L; Manganaro, D; Varchetta, S; Gatti, N; Riva, A; Monforte, AD; Galli, M
      Maintenance of naive and Th1CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Knobel, H; Miro, TM; Domingo, P; Rivero, A; Marquez, M; Force, L; Gonzalez, A; De Miguel, V; Sanz, J; Boix, V; Blanco, JL; Locutura, J
      Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: A double-blind placebo- controlled trial: The GESIDA 09/99 study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Manfredi, R
      A cross-sectional survey of HIV genotype mutations conferring resistance to all nonnucleoside reverse transcriptase inhibitors and related features, at the time of failure of antiretroviral therapy in the real world

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Ruiz, L; Negredo, E; Domingo, P; Paredes, R; Francia, E; Balague, M; Gel, S; Bonjoch, A; Fumaz, CR; Johnston, S; Romeu, J; Lange, J; Clotet, B
      Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Jensen-Fangel, S; Thomsen, HF; Larsen, L; Black, FT; Obel, N
      The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients - A prospective, open-label, controlled, randomized study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Gerber, JG; Rosenkranz, S; Segal, Y; Aberg, J; D'Amico, R; Mildvan, D; Gulick, R; Hughes, V; Flexner, C; Aweeka, F; Hsu, A; Gal, J
      Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Sabin, CA; Fisher, M; Churchill, D; Pozniak, A; Hay, P; Easterbrook, P; Williams, I
      Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Deeks, SG
      Nonnucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Dailly, E; Thomas, L; Kergueris, MF; Jolliet, P; Bourin, M
      High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavirand saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction

      JOURNAL OF CHROMATOGRAPHY B
    13. Lopez, RM; Pou, L; Gomez, MR; Ruiz, I; Monterde, J
      Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    14. Fan, B; Stewart, JT
      Determination of zidovudine/zalcitabine/nevirapine in human plasma by ion-pair HPLC

      JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
    15. Maggiolo, F
      Comparison of NNRTIs in antiretroviral-experienced patients

      INTERNATIONAL JOURNAL OF STD & AIDS
    16. Lafeuillade, A
      Factors affecting adherence and convenience in antiretroviral therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    17. Treluyer, JM
      Pharmacology of antiretroviral agents in children

      ARCHIVES DE PEDIATRIE
    18. Manfredi, R; Chiodo, F
      Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    19. Mirochnick, M; Siminski, S; Fenton, T; Lugo, M; Sullivan, JL
      Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    20. Zuber, B; Bottiger, D; Benthin, R; Ten Haaft, P; Heeney, J; Wahren, B; Oberg, B
      An in vivo model for HIV resistance development

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    21. Clarke, SM; Mulcahy, FM; Tjia, J; Reynolds, HE; Gibbons, SE; Barry, MG; Back, DJ
      The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    22. Veldkamp, AI; Weverling, GJ; Lange, JMA; Montaner, JSG; Reiss, P; Cooper, DA; Vella, S; Hall, D; Beijnen, JH; Hoetelmans, RMW
      High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

      AIDS
    23. Shulman, N; Zolopa, AR; Passaro, D; Shafer, RW; Huang, W; Katzenstein, D; Israelski, DM; Hellmann, N; Petropoulos, C; Whitcomb, J
      Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy

      AIDS
    24. Eshleman, SH; Mracna, M; Guay, LA; Deseyve, M; Cunningham, S; Mirochnick, M; Musoke, P; Fleming, T; Fowler, MG; Mofenson, LM; Mmiro, F; Jackson, JB
      Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)

      AIDS
    25. Fagot, JP; Mockenhaupt, M; Bouwes-Bavinck, JN; Naldi, L; Viboud, C; Roujeau, JC
      Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

      AIDS
    26. Martinez, E; Arnedo, M; Giner, V; Gil, C; Caballero, M; Alos, L; Garcia, F; Holtzer, C; Mallolas, J; Miro, JM; Pumarola, T; Gatell, JM
      Lymphoid tissue viral burden and duration of viral suppression in plasma

      AIDS
    27. Frater, AJ; Beardall, A; Ariyoshi, K; Churchill, D; Galpin, S; Clarke, JR; Weber, JN; McClure, MO
      Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

      AIDS
    28. Clumeck, N; Goebel, F; Rozenbaum, W; Gerstoft, J; Staszewski, S; Montaner, J; Johnson, M; Gazzard, B; Stone, C; Athisegaran, R; Moore, S
      Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

      AIDS
    29. Walmsley, SL; Kelly, DV; Tseng, AL; Humar, A; Harrigan, PR
      Non-nucleoside reverse transcriptase inhibitor failure impairs HIV-RNA responses to efavirenz-containing salvage antiretroviral therapy

      AIDS
    30. Bartlett, JA; DeMasi, R; Quinn, J; Moxham, C; Rousseau, F
      Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

      AIDS
    31. Martinez, E; Blanco, JL; Arnaiz, JA; Perez-Cuevas, JB; Mocroft, A; Cruceta, A; Marcos, MA; Milinkovic, A; Garcia-Viejo, MA; Mallolas, J; Carne, X; Phillips, A; Gatell, JM
      Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

      AIDS
    32. Conway, B; Wainberg, MA; Hall, D; Harris, M; Reiss, P; Cooper, D; Vella, S; Curry, R; Robinson, P; Lange, JMA; Montaner, JSG
      Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine

      AIDS
    33. Veldkamp, AI; van Heeswijk, RPG; Mulder, JW; Meenhorst, PL; Hoetelmans, RMW; Lange, JMA; Beijnen, JH
      Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine

      THERAPEUTIC DRUG MONITORING
    34. Bart, PA; Rizzardi, PG; Gallant, S; Golay, KP; Baumann, P; Pantaleo, G; Eap, CB
      Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir

      THERAPEUTIC DRUG MONITORING
    35. van Heeswijk, RPG; Veldkamp, AI; Mulder, JW; Meenhorst, PL; Beijnen, JH; Lange, JMA; Hoetelmans, RMW
      Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine

      THERAPEUTIC DRUG MONITORING
    36. Hetherington, S; McGuirk, S; Powell, G; Cutrell, A; Naderer, O; Spreen, B; Lafon, S; Pearce, G; Steel, H
      Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

      CLINICAL THERAPEUTICS
    37. Delaugerre, C; Rohban, R; Simon, A; Mouroux, M; Tricot, C; Agher, R; Huraux, JM; Katlama, C; Calvez, V
      Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen

      JOURNAL OF MEDICAL VIROLOGY
    38. von Moltke, LL; Greenblatt, DJ; Granda, BW; Giancarlo, GM; Duan, SX; Daily, JP; Harmatz, JS; Shader, RI
      Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors

      JOURNAL OF CLINICAL PHARMACOLOGY
    39. Buckheit, RW; Watson, K; Fliakas-Boltz, V; Russell, J; Loftus, TL; Osterling, MC; Turpin, JA; Pallansch, LA; White, EL; Lee, JW; Lee, SH; Oh, JW; Kwon, HS; Chung, SG; Cho, EH
      SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    40. Sullivan, JL; Luzuriaga, K
      The changing face of pediatric HIV-1 infection

      NEW ENGLAND JOURNAL OF MEDICINE
    41. Maga, G; Ramunno, A; Nacci, V; Locatelli, GA; Spadari, S; Fiorini, I; Baldanti, F; Paolucci, S; Zavattoni, M; Bergamini, A; Galletti, B; Muck, S; Hubscher, U; Giorgi, G; Guiso, G; Caccia, S; Campiani, G
      The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464 - A novel generation of nonnucleoside inhibitors

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Claudio, GA; Martin, AF; Perrino, SD; Velasco, AA
      DRESS syndrome associated with novirapine therapy

      ARCHIVES OF INTERNAL MEDICINE
    43. Nieuwkerk, PT; Sprangers, MAG; Burger, DM; Hoetelmans, RMW; Hugen, PWH; Danner, SA; van der Ende, ME; Schneider, MME; Schrey, G; Meenhorst, PL; Sprenger, HG; Kauffmann, RH; Jambroes, M; Chesney, MA; de Wolf, F; Lange, JMA
      Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study

      ARCHIVES OF INTERNAL MEDICINE
    44. Stewart, KA
      Toward a historical perspective on sexuality in Uganda: The reproductive lifeline technique for grandmothers and their daughters

      AFRICA TODAY
    45. Torti, C; Pozniak, A; Nelson, M; Hertogs, K; Gazzard, BG
      Distribution of K103N and/or Y181CHIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors

      JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
    46. Stringer, JSA; Rouse, DJ; Vermund, SH; Goldenberg, RL; Sinkala, M; Stinnett, AA
      Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    47. Rainey, PM; Friedland, G; McCance-Katz, EF; Andrews, L; Mitchell, SM; Charles, C; Jatlow, P
      Interaction of methadone with didanosine and stavudine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    48. Shulman, NS; Zolopa, AR; Passaro, DJ; Murlidharan, U; Israelski, DM; Brosgart, CL; Miller, MD; Van Doren, S; Shafer, RW; Katzenstein, DA
      Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: Clinical and genotypic predictors of virologic response

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    49. Hollanders, RMF; Kolmer, EWJV; Burger, DM; Wuis, EW; Koopmans, PP; Hekster, YA
      Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptaseinhibitor, in human plasma by reversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    50. Darbyshire, J
      Therapeutic interventions in HIV infection - a critical view

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    51. Wit, FWNM
      Experience with nevirapine in previously treated HIV-1-infected individuals

      ANTIVIRAL THERAPY
    52. Hogberg, M; Morrison, I
      HIV-1 non-nucleoside reverse transcriptase inhibitors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    53. Palomares, JC; Perea, EJ; Terrero, E; Torres, JM; Garcia, ML; Romero, J; Alejo, A
      Detection of resistant mutations in the reverse transcriptase of HIV-1-infected children

      CLINICAL MICROBIOLOGY AND INFECTION
    54. Chen, F; Pau, AK; Piscitelli, SC
      Update on preventing vertical transmission of HIV type 1

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    55. Gangar, M; Arias, G; O'Brien, JG; Kemper, CA
      Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdine

      ANNALS OF PHARMACOTHERAPY
    56. Rieder, MJ; Dekaban, GA
      Deja vu all over again: Adverse reactions to nonnucleoside reverse transcriptase inhibitors

      ANNALS OF PHARMACOTHERAPY
    57. Piroth, L; Grappin, M; Sgro, C; Buisson, M; Duong, M; Chavanet, P
      Recurrent NNRTI-induced hepatotoxicity in an HIV-HCV-coinfected patient

      ANNALS OF PHARMACOTHERAPY
    58. Raffi, F; Bonnet, B; Ferre, V; Esnault, JL; Perre, P; Reliquet, V; Leautez, S; Bouillant, C; Vergnoux, O; Weinbreck, P
      Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA

      CLINICAL INFECTIOUS DISEASES
    59. Bossi, P; Colin, D; Bricaire, F; Caumes, E
      Hypersensitivity syndrome associated with efavirenz therapy

      CLINICAL INFECTIOUS DISEASES
    60. Gerber, JG
      Using pharmacokinetics to optimize antiretroviral drug-drug interactions the treatment of human immunodeficiency virus infection

      CLINICAL INFECTIOUS DISEASES
    61. Harris, M; Montaner, JSG
      Clinical uses of non-nucleoside reverse transcriptase inhibitors

      REVIEWS IN MEDICAL VIROLOGY
    62. Ren, J; Milton, J; Weaver, KL; Short, SA; Stuart, DI; Stammers, DK
      Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase

      STRUCTURE
    63. Luo, CW
      Strategies for prevention of mother-to-child transmission of HIV

      REPRODUCTIVE HEALTH MATTERS
    64. Hankins, C
      Preventing mother-to-child transmission of HIV in developing countries: Recent developments and ethical implications

      REPRODUCTIVE HEALTH MATTERS
    65. Hogberg, M; Engelhardt, P; Vrang, L; Zhang, H
      Bioisosteric modification of PETT-HIV-1 RT-inhibitors: Synthesis and biological evaluation

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    66. Clarke, S; Harrington, P; Condon, C; Kelleher, D; Smith, OP; Mulcahy, F
      Late onset hepatitis and prolonged deterioration in hepatic function associated with nevirapine therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    67. Kishimoto, W; Takano, J; Senda, C; Ishiguro, N; Sakai, K; Igarashi, T
      Quantitative prediction of in vivo drug interactions between nevirapine and antifungal agents from in vitro data in rats

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    68. De Clercq, E
      Structures and activities of non-nucleoside reverse transcriptase inhibitors (NNRTIs).

      MEDECINE ET MALADIES INFECTIEUSES
    69. Khaliq, Y; Gallicano, K; Seguin, I; Fyke, K; Carignan, G; Bulman, D; Badley, A; Cameron, DW
      Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    70. Manfredi, R; Chiodo, F
      First-line nevirapine in combination with nucleoside analogues compared with nevirapine added to a salvage HAART

      INFECTION
    71. van Heeswijk, RPG; Veldkamp, AI; Mulder, JW; Meenhorst, PL; Wit, FWNM; Lange, JMA; Danner, SA; Foudraine, NA; Kwakkelstein, MO; Reiss, P; Beijnen, JH; Hoetelmans, RMW
      The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals

      AIDS
    72. Wegner, SA; Brodine, SK; Mascola, JR; Tasker, SA; Shaffer, RA; Starkey, MJ; Barile, A; Martin, GJ; Aronson, N; Emmons, WW; Stephan, K; Bloor, S; Vingerhoets, J; Hertogs, K; Larder, B
      Prevalence of genotypic and phenotypic resistance to anti-retroviral drugsin a cohort of therapy-naive HIV-1 infected US military personnel

      AIDS
    73. Barreiro, P; Soriano, V; Blanco, F; Casimiro, C; de la Cruz, JJ; Gonzalez-Lahoz, J
      Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

      AIDS
    74. Casado, JL; Hertogs, K; Ruiz, L; Dronda, F; Van Cauwenberge, A; Arno, A; Garcia-Arata, I; Bloor, S; Bonjoch, A; Blazquez, J; Clotet, B; Larder, B
      Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen

      AIDS
    75. Zhou, XJ; Havlir, DV; Richman, DD; Acosta, EP; Hirsch, M; Collier, AC; Tebas, P; Sommadossi, JP
      Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients

      AIDS
    76. Garcia, F; Knobel, H; Sambeat, MA; Arrizabalaga, J; Aranda, M; Romeu, J; Dalmau, D; Segura, F; Gomez-Sirvent, JL; Ferrer, E; Cruceta, A; Gallart, T; Pumarola, T; Miro, JM; Gatell, JM
      Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study

      AIDS
    77. Barreiro, P; Soriano, V; Casas, E; Estrada, V; Tellez, MJ; Hoetelmans, R; de Requena, DG; Jimenez-Nacher, I; Gonzalez-Lahoz, J
      Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

      AIDS
    78. Taylor, S; van Heeswijk, RPG; Hoetelmans, RMW; Workman, J; Drake, SM; White, DJ; Pillay, D
      Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men

      AIDS
    79. Kuritzkes, DR; Bassett, RL; Johnson, VA; Marschner, IC; Eron, JJ; Sommadossi, JP; Acosta, EP; Murphy, RL; Fife, K; Wood, K; Bell, D; Martinez, A; Pettinelli, CB
      Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370

      AIDS
    80. Precious, HM; Gunthard, HF; Wong, JK; D'Aquila, RT; Johnson, VA; Kuritzkes, DR; Richman, DD; Brown, AJL
      Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy

      AIDS
    81. Merchant, RC
      Nonoccupational HIV postexposure prophylaxis: A new role for the emergencydepartment

      ANNALS OF EMERGENCY MEDICINE
    82. Pirounaki, M; Vander Heyden, NA; Arens, M; Ratner, L
      Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line

      JOURNAL OF VIROLOGICAL METHODS
    83. Sweat, M; Gregorich, S; Sangiwa, G; Furlonge, C; Balmer, D; Kamenga, C; Grinstead, O; Coates, T
      Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania

      LANCET
    84. Wood, E; Braitstein, P; Montaner, JSG; Schechter, MT; Tyndall, MW; O'Shaughnessy, MV; Hogg, RS
      Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa

      LANCET
    85. Taylor, GP; Lyall, EGH; Back, D; Ward, C; Tudor-Williams, G
      Pharmacological implications of lengthened in-utero exposure to nevirapine

      LANCET
    86. Carpenter, CCJ; Cooper, DA; Fischl, MA; Gatell, JM; Gazzard, BG; Hammer, SM; Hirsch, MS; Jacobsen, DM; Katzenstein, DA; Montaner, JSG; Richman, DD; Saag, MS; Schechter, M; Schooley, RT; Vella, S; Yeni, PG; Volberding, PA
      Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    87. Bacheler, LT; Anton, ED; Kudish, P; Baker, D; Bunville, J; Krakowski, K; Bolling, L; Aujay, M; Wang, XV; Ellis, D; Becker, MF; Lasut, AL; George, HJ; Spalding, DR; Hollis, G; Abremski, K
      Human immunodeficiency virus type 1 mutations selected in patients failingefavirenz combination therapy

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    88. Maga, G; Ubiali, D; Salvetti, R; Pregnolato, M; Spadari, S
      Selective interaction of the human immunodeficiency virus type 1 reverse transcriptase nonnucleoside inhibitor efavirenz and its thio-substituted analog with different enzyme-substrate complexes

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    89. Hertogs, K; Bloor, S; De Vroey, V; Van den Eynde, C; Dehertogh, P; Van Cauwenberge, A; Sturmer, M; Alcorn, T; Wegner, S; Van Houtte, M; Miller, V; Larder, BA
      A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    90. Joly, V; Moroni, M; Concia, E; Lazzarin, A; Hirschel, B; Jost, J; Chiodo, F; Bentwich, Z; Love, WC; Hawkins, DA; Wilkins, EGL; Gatell, AJ; Vetter, N; Greenwald, C; Freimuth, WW; De Cian, W
      Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    91. Sibaud, V; Billon, C; Barcat, D; Bernard, N; Geniaux, M
      Hypersensitivity syndrome associated with nevirapine therapy

      THERAPIE
    92. Pedersen, OS; Pedersen, EB
      The flourishing syntheses of non-nucleoside reverse transcriptase inhibitors

      SYNTHESIS-STUTTGART
    93. McIntyre, J; Gray, G
      Antiretroviral treatment to prevent mother-to-child transmission of HIV-1

      SOUTH AFRICAN JOURNAL OF SCIENCE
    94. Hayashi, T
      New therapy reduces AIDS passed to fetuses and costs less

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    95. Dona, C; Soriano, V; Barreiro, P; Jimenez-Nacher, I; Gonzalez-Lahoz, J
      Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program

      MEDICINA CLINICA
    96. Fernandez, DG; Briones, VGP; Sanchez, JM; Rodellas, AC
      Stevens-Johnson Syndrome associated with nevirapine

      REVISTA CLINICA ESPANOLA
    97. Munoz, RP; Gonzalez, JS; Garcia, RB; Solero, MM
      Necrotic plaques in patient with chronic renal failure

      REVISTA CLINICA ESPANOLA
    98. Rodrigo, MDB; Rodriguez, MA; Garcia, MLL; Llera, JLG
      Nevirapine induces abstinence symptoms among HIV-infected patients on a methadone maintenance programme

      REVISTA CLINICA ESPANOLA
    99. Joly, V; Yeni, P
      Non-nucleosidic reverse transcriptase inhibitors

      ANNALES DE MEDECINE INTERNE
    100. Regazzi, MB; Villani, P; Maserati, R; Seminari, E; Pan, A; LoCaputo, F; Gambarana, E; Fiocchi, C
      Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients

      JAC. Journal of antimicrobial chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/14 alle ore 06:56:57